Evidence map›Paper›PMID 32187988›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Carbonized Dehydroascorbic Acid: Aim for Targeted Repair of Graphene Defects and Bridge Connection of Graphene Sheets with Small Size.

Jing Li, Jinfeng Lai, Jialiang Liu, Rubai Lei, Yuxun Chen

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jing LiSchool of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, China.ORCID 0000-0002-0198-0974
Jinfeng LaiSchool of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, China.
Jialiang LiuSchool of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, China.
Rubai LeiSchool of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, China.ORCID 0000-0002-3710-3092
Yuxun ChenSchool of Mechanical and Automotive Engineering, South China University of Technology, Guangzhou 510641, China.

Funding

The "13th Five-Year Plan" Civil Aerospace Technology Pre-research Project of the State Administration of Science, Technology, and Industry for National Defense A2180150The Joint Fund for Equipment Pre-research of Ministry of Education of China A02022520
6 · The paper itself

Abstract

The thermal dissipation issue of electronics devices becomes increasingly prominent as they evolve to smaller sizes and more complicated structures. Therefore, the development of materials with excellent heat conduction properties and light weight turns out to be an urgent demand to solve the heat transfer problem of electronics devices with high performance. For this purpose, we put forward an innovative strategy that carbonized dehydroascorbic acid (CDA) be applied to graphene layers for the targeted repair of defects among them and bridge connection of the layers to produce graphene heat conduction materials with excellent properties. Firstly, hydrogen bonds formed from dehydroascorbic acid (DHAA, products of the oxidation of vitamin C) and each of ketone, carboxyl, and oxhydryl groups on graphene layers were absorbed at targeted locations where oxidation graphene produces defects, then targeted repair was conducted for those defects to be filled and for the graphene layers of a small size to grow into large sheet materials with improved continuity by CDA generated in thermally pressing reduction reaction at 800 °C. In our investigation, the planar thermal conductivity of rGO/VC membrane reached 1031.9 ± 10.2 Wm

Indexed as

carbonized dehydroascorbic acidoxidized graphenetargeted repairthermal conductivitythermal reduction

Identifiers

PMID32187988
PMCPMC7153701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.